FDA Product Code NST: Autoantibodies, Acetylcholine Receptor, Acetylcholine Blocking And Non-blocking

The Device Is An Immunoassay Indicated As An Aid In The Diagnosis Of Myasthenia Gravis, An Autoimmune Disease Characterized By Exercise-induced Muscle Weakness Temporarily Relieved By Cessation Of Exercise. Autoantibody, When Present In Serum, Interferes With The Binding Of Acetylcholine, A Neural Transmitter At The Junction Of Nerves With Muscles. Autoantibody Can Also Bind To Other Portions Of The Acetylcholine Receptor Without Interfering With Acetylcholine Binding. Presence Of Autoantibody Along With Clinical Signs And Symptoms Are Usually Highly Suggestive Of Myasthenia Gravis. Acetylcholine Receptor Autoantibody Can Also Occur In The Presence Of Autoantibodies To Other Body Substances.

Leading manufacturers include Kronus Market Development Associates, Inc. and Ibl-Hamburg GmbH.